Physician profile
Grace E Lowen
NPI 1285266403
$876.01
in general payments reported to CMS, 2019-2025
23 companies · $19.72 in 2025
The $19.72 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $731 · 2022: $67.62 · 2023: $58.04 · 2025: $19.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $178.54 | 2021-2022 | |
| Esperion Therapeutics, INC. | $93.04 | 2021 | |
| Antares Pharma, INC. | $61.73 | 2021 | |
| Amgen INC. | $56.90 | 2021 | |
| Astellas Pharma US INC | $52.44 | 2021-2023 | Myrbetriq |
| Lilly USA, LLC | $43.40 | 2021 | |
| Exact Sciences Corporation | $40.87 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $36.36 | 2021 | |
| Sunovion Pharmaceuticals INC. | $34.11 | 2021 | |
| Amarin Pharma, INC. | $33.59 | 2021 | |
| Clarus Therapeutics INC. | $29.17 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $25.79 | 2021 | |
| Abbott Laboratories | $23.77 | 2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $20.56 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.44 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $18.77 | 2022 | |
| Insulet Corporation | $17.87 | 2021 | |
| Genentech USA, INC. | $16.69 | 2021 | |
| Glaxosmithkline, LLC. | $15.93 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.56 | 2021 | |
| Pfizer INC. | $14.05 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Lowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.